Replication-selective microbiological agents: fighting cancer with targeted germ warfare

被引：47
|
作者：
Kirn, DH [1 ]
机构：
[1] Hammersmith Hosp, Imperial Coll Sch Med, Program Viral & Genet Therapy Canc, Imperial Canc Res Fund,Mol Oncol Unit, London W12 0NN, England
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2000年 / 105卷 / 07期
关键词：
D O I：
10.1172/JCI9761
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：837 / 839
页数：3
相关论文
共 46 条
  • [31] A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer
    Small, Eric J.
    Carducci, Michael A.
    Burke, James M.
    Rodriguez, Ron
    Fong, Lawrence
    van Ummersen, Lynn
    Yu, D. C.
    Aimi, Junko
    Ando, Dale
    Working, Peter
    Kirn, David
    Wilding, George
    MOLECULAR THERAPY, 2006, 14 (01) : 107 - 117
  • [32] Identification of the human IAI.3B promoter element and its use in the construction of a replication-selective adenovirus for ovarian cancer therapy
    Hamada, K
    Kohno, S
    Iwamoto, M
    Yokota, H
    Okada, M
    Tagawa, M
    Hirose, S
    Yamasaki, K
    Shirakata, Y
    Hashimoto, K
    Ito, M
    CANCER RESEARCH, 2003, 63 (10) : 2506 - 2512
  • [33] Adenoviral gene therapy for cancer: From vectors to targeted and replication competent agents (Review)
    Bauerschmitz, GJ
    Barker, SD
    Hemminki, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 21 (06) : 1161 - 1174
  • [34] Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer
    Coukos, G
    Makrigiannakis, A
    Kang, EH
    Caparelli, D
    Benjamin, I
    Kaiser, LR
    Rubin, SC
    Albelda, SM
    Molnar-Kimber, KL
    CLINICAL CANCER RESEARCH, 1999, 5 (06) : 1523 - 1537
  • [35] Therapeutic efficacy of midkine promoter-based replication-selective adenovirus vector to target the midkine-expressing human bladder cancer cells
    Terao, S
    Shirakawa, T
    Goda, K
    Fujisawa, M
    Gotoh, A
    JOURNAL OF GENE MEDICINE, 2006, 8 (03): : 389 - 389
  • [36] Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
    Kirn, D
    GENE THERAPY, 2001, 8 (02) : 89 - 98
  • [37] DETECTION OF CIRCULATING TUMOR CELLS IN GASTRIC CANCER PATIENTS USING TELOMERASE-SPECIFIC REPLICATION-SELECTIVE ADENOVIRAL AGENT: PROSPECTIVE FEASIBILITY STUDY
    Ito, H.
    Inoue, H.
    Tsujino, Y.
    Sando, N.
    Kimura, S.
    Ozawa, T.
    Masago, A.
    Urata, Y.
    Tanaka, J.
    Kudo, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 73 - 73
  • [38] A Cox-2 promoter-based replication-selective adenoviral vector to target the Cox-2-expressing human bladder cancer cells
    Shirakawa, T
    Hamada, K
    Zhang, ZJ
    Okada, H
    Tagawa, M
    Kamidono, S
    Kawabata, M
    Gotoh, A
    CLINICAL CANCER RESEARCH, 2004, 10 (13) : 4342 - 4348
  • [39] Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients
    Nemunaitis, J
    Cunningham, C
    Tong, AW
    Post, L
    Netto, G
    Paulson, AS
    Rich, D
    Blackburn, A
    Sands, B
    Gibson, B
    Randlev, B
    Freeman, S
    CANCER GENE THERAPY, 2003, 10 (05) : 341 - 352
  • [40] Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
    D Kirn
    Gene Therapy, 2001, 8 : 89 - 98
12345